Chemical formula: C₂₀H₂₅NO₂ Molecular mass: 311.425 g/mol PubChem compound: 68861
Dienogest is a nortestosterone derivative with no androgenic but rather an antiandrogenic activity of approximately one third of that of cyproterone acetate. Dienogest binds to the progesterone receptor of the human uterus with only 10% of the relative affinity of progesterone.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G03DB08 | Dienogest | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DB Pregnadien derivatives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| VISANNE Tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Dienogest is an active ingredient of these brands:
Austria (AT)
Brazil (BR)Canada (CA)Cyprus (CY)
Ecuador (EC)
Estonia (EE)Finland (FI)France (FR)Germany (DE)Ireland (IE)Japan (JP)Lithuania (LT)Mexico (MX)
Netherlands (NL)
Poland (PL)
Spain (ES)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
